D-Chiro-Inositol
D-Chiro-Inositol
TL;DR
D-chiro-inositol is an insulin second messenger used in PCOS, usually alongside myo-inositol in a 40:1 ratio. High solo doses may worsen ovarian function.
Ideal For
- Women with PCOS, especially the insulin-resistant phenotype
- Women seeking to restore ovulation and cycle regularity
- People with metabolic syndrome or impaired glucose tolerance
- Women undergoing IVF, where inositol supports oocyte quality
Avoid If
- You are taking high-dose DCI alone while trying to conceive
- You are on insulin or sulfonylureas without glucose monitoring
Frequently Asked Questions
Overview
D-chiro-inositol (DCI) is one of nine inositol stereoisomers and works as a second messenger in insulin signalling, principally in glycogen synthesis. It became prominent after 1999 trials in women with polycystic ovary syndrome reported improved insulin sensitivity, lower androgens and restored ovulation.
The story became more nuanced with the discovery of the "DCI paradox". Ovarian tissue is never insulin resistant, and an enzyme called epimerase converts myo-inositol to DCI in proportion to insulin signalling. In PCOS, hyperinsulinaemia drives excessive ovarian conversion, so the ovary ends up myo-inositol depleted and DCI enriched. Since myo-inositol is what FSH signalling and oocyte quality depend on, giving large solo doses of DCI can make ovarian outcomes worse, and trials have shown declining oocyte quality as DCI dose rose.
The resolution is the 40:1 ratio of myo-inositol to DCI, which matches the physiological plasma ratio and is now standard in the inositol literature: 2000 mg myo-inositol with 50 mg DCI, twice daily. That combination improves menstrual regularity, ovulation rates, insulin resistance and androgen levels with a strong safety record. DCI alone still has a role in metabolic rather than reproductive contexts.
How It Works
- Acts as the second messenger for insulin-mediated glycogen synthesis
- Improves peripheral insulin sensitivity, indirectly reducing ovarian androgen production
- Formed from myo-inositol by an insulin-dependent epimerase
- Excess ovarian DCI depletes myo-inositol needed for FSH signalling and oocyte quality
- Combined 40:1 dosing restores the physiological plasma ratio
Quick Facts
- Reduces excess androgens
- Improves insulin sensitivity
- Supports ovulation
- Balances hormone levels
- Best in 40:1 ratio with myo-inositol
Benefits & Outcomes
Hormonal Balance
DCI lowers androgens and improves insulin sensitivity in PCOS, but dosing above physiological levels can backfire.
Ovulation Support
DCI can restore ovulation in insulin-resistant PCOS, though high doses may reduce oocyte quality.
Menstrual Cycle Regulation
Cycle regularity improves in some PCOS trials, but myo-inositol dominant formulas are better supported.
Supporting Research5 studies
Experts' opinion on inositols in treating polycystic ovary syndrome and non-insulin dependent diabetes mellitus: a further help for human reproduction and beyond
Facchinetti F, Bizzarri M, Benvenga S +13 more
The 40:1 myo-inositol to D-chiro-inositol ratio reflects physiological plasma proportions and is recommended for restoring ovulation and insulin sensitivity, with high-dose D-chiro-inositol potentially detrimental to oocyte quality.
Ovulatory and Metabolic Effects of D-Chiro-Inositol in the Polycystic Ovary Syndrome
Nestler JE, Jakubowicz DJ, Reamer P +2 more
Nineteen of 22 women receiving D-chiro-inositol ovulated, as compared with 6 of 22 in the placebo group.
Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-Based PCOS Guidelines
Fitz V, Graca S, Mahalingaiah S +5 more
Inositol improved fasting insulin and HOMA-IR versus placebo, with low-certainty effects on ovulation, hirsutism and androgens.
Comparative efficacy of oral insulin sensitizers metformin, thiazolidinediones, inositol, and berberine in improving endocrine and metabolic profiles in women with PCOS: a network meta-analysis
Zhao H, et al.
Myo-inositol combined with D-chiro-inositol and metformin combined with thiazolidinediones appear superior to metformin alone in improving insulin resistance and decreasing total testosterone. Myo-inositol combined with D-chiro-inositol is particularly efficacious in menstrual recovery.
Update on the Combination of Myo-Inositol / D-Chiro-Inositol for the Treatment of Polycystic Ovary Syndrome
Lete I, Martinez A, Lasaga I +2 more
High-dose isolated D-chiro-inositol has been associated with reduced oocyte quality, the so-called D-chiro-inositol paradox.
Safety Information
Potential Side Effects
Very well tolerated. Mild nausea, gas or loose stools at higher doses, generally at intakes well above 4 g of total inositol per day.
Contraindications
No absolute contraindications. The practical caution is against high-dose DCI without myo-inositol in women pursuing fertility, given evidence of declining oocyte quality with rising DCI dose.
Drug Interactions
- Metformin — complementary rather than conflicting; often combined in PCOS
- Insulin and sulfonylureas — additive glucose lowering, monitor
- No established pharmaceutical interactions otherwise
Pregnancy & Breastfeeding
Pregnancy: likely_safe
Breastfeeding: insufficient_data
Dosage Guidelines
Dosage Used in Studies
600-1200 mg
Best Time to Take
Morning and evening
Best Form
Myo-inositol and D-chiro-inositol combined in a 40:1 ratio
Bioavailability
Isomer of inositol. May support insulin sensitivity and ovarian function. Often combined with myo-inositol in 40:1 ratio (myo:DCI) for PCOS. Well tolerated. Limited side effects.
Forms Compared
Myo-inositol plus DCI 40:1
D-chiro-inositol alone
Pinitol
Food & Timing
With or without food; splitting into two doses is standard
Medical Disclaimer
The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.
Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.